Riskpilot← Back to searchSign inGet full accessNORDIC PHARMA LOGISTICS AS
ASActiveOrg 995628953Østre Kullerød 2, 3241 SandefjordWholesale of pharmaceutical and medical goods · NACE 4646Est. 20100 employees
Revenue 2021
NOK 0
EBITDA margin
—
-3% vs 2020
Equity ratio
55.6%
Financial strength
Net profit 2021
NOK -11K
-7% vs 2020
| Revenue | NOK 0 | — |
| EBITDA | NOK -11K | -3% |
| Net profit | NOK -11K | -7% |
| Total assets | NOK 94K | -1% |
| Equity | NOK 52K | -18% |
| Employees | 0 | — |
Legal name
NORDIC PHARMA LOGISTICS AS
Org number
995628953
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. juli 2010
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap.
Company purpose
Handel med legemidler, sykepleieartikler, andre varer og tjenester som står i forbindelse med dette, herunder å eie aksjer i andre selskaper.
Address
Østre Kullerød 2, 3241 Sandefjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −3 | −9 | −11 | −11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −3 | −9 | −11 | −11 |
| Net financials | 0 | 1 | 1 | 0 | −0 |
| Profit before tax | 0 | −2 | −8 | −11 | −11 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −2 | −8 | −11 | −11 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 97 | 95 | 97 | 95 | 94 |
| Equity | 85 | 83 | 75 | 64 | 52 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 | 12 | 22 | 31 | 42 |
| Total debt | 12 | 12 | 22 | 31 | 42 |
EBITDA margin
-1101500.0%
This company
15.8%
Market median
-6971619% vs market
20172021
Equity ratio
55.6%
This company
38.2%
Market median
+46% vs market
20172021
Return on equity
-21.9%
This company
18.4%
Market median
-219% vs market
20172021
Net profit margin
-1149700.0%
This company
8.1%
Market median
-14193927% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GA Chief Executive Officer | Chief Executive Officer | 2014 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (4) | ||
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2019 – 2019 | |
| Chairman | 2019 – 2019 | |
| Board of Directors | 2019 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORDIC PHARMA LOGISTICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Arne Eide | Chief Executive Officer | 0 companies |
| Frode Hammer | Board of Directors | 0 companies |
| Live Bertha Haukvik | Board of Directors | 0 companies |
| Wenlong Luo | Chairman | 0 companies |
| Elisabeth Haug | Board of Directors | 0 companies |
| Ole Vinje | Chairman | 0 companies |
| Stig Henning Pedersen | Board of Directors | 0 companies |